StockData
Anixa Biosciences Inc logo

Anixa Biosciences Inc (ANIX) stock

ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026Score 6/30
$2.67+0.12 (+4.71%)

Close on Nov 17, 2026Market cap $92.82MP/E –Yield –

Anixa Biosciences total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

No total debt figures for Anixa Biosciences

Anixa Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Anixa Biosciences figures

See a number that looks wrong?